Back to: products

Global Active Pharmaceutical Ingredients (API) Market 2021-2027 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application

PrintEmail
Feb 2021 - 223 Pages - From $2,980
(Excel Data Sheet: $1,800)
Description

The report cover may be different from the image shown.

Product and Price

By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.

Global active pharmaceutical ingredients (API) market will reach $313.6 billion by 2027, growing by a revised 2020-2027 CAGR of 7.1% owing to the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic.
Highlighted with 150 tables and 101 figures, this 223-page report “Global Active Pharmaceutical Ingredients (API) Market 2021-2027 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2020 and provides forecast from 2021 till 2027 with 2020 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global API market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Region.

Based on Synthesis, the global market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
Synthetic API
• Branded Synthetic API
• Generic Synthetic API
Biotech API by Drug Type:
• Monoclonal Antibodies
• Recombinant Proteins
• Vaccines
• Other Biotech APIs
Biotech API by Customer Base:
• Innovative Biologic API
• Generic Biosimilar API
Biotech API by Expression Technology:
• Mammalian Expression
• Microbial Expression
• Yeast Expression
• Insect Expression
• Other Expression Technologies
HPAPI
• Branded HPAPI
• Generic HPAPI

Based on Manufacturing Process, the global market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
Captive Manufacturing
• Branded Captive API
• Generic Captive API
Merchant Manufacturing by Drug Type:
• Branded Merchant API
• Generic Merchant API
Merchant Manufacturing by Drug Synthesis:
• Merchant Synthetic API
• Merchant Biotech API

Based on Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Pulmonary Disorders
• Orthopedics
• Other Applications

Based on Drug Type, the global market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
• Branded Prescription Drugs
• Generic Prescription Drugs
• OTC Drugs

Geographically, the following regions together with the listed national/local markets are fully investigated:
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (U.S., Canada, and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• RoW (Saudi Arabia, UAE, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2017-2027. The breakdown of all regional markets by country and split of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global API market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 12
1.1 Industry Definition and Research Scope 12
1.1.1 Industry Definition 12
1.1.2 Research Scope 13
1.2 Research Methodology 16
1.2.1 Overview of Market Research Methodology 16
1.2.2 Market Assumption 17
1.2.3 Secondary Data 17
1.2.4 Primary Data 17
1.2.5 Data Filtration and Model Design 19
1.2.6 Market Size/Share Estimation 20
1.2.7 Research Limitations 21
1.3 Executive Summary 22
2 Market Overview and Dynamics 24
2.1 Market Size and Forecast 24
2.1.1 Impact of COVID-19 on World Economy 25
2.1.2 Impact of COVID-19 on the Market 28
2.2 Major Growth Drivers 30
2.3 Market Restraints and Challenges 35
2.4 Emerging Opportunities and Market Trends 38
2.5 Porter’s Fiver Forces Analysis 42
3 Segmentation of Global Market by Synthesis 46
3.1 Market Overview by Synthesis 46
3.2 Synthetic API 48
3.2.1 Branded Synthetic API 49
3.2.2 Generic Synthetic API 50
3.3 Biotech API 51
3.3.1 Biotech API by Drug Type 52
3.3.1.1 Monoclonal Antibodies 53
3.3.1.2 Recombinant Proteins 54
3.3.1.3 Vaccines 55
3.3.1.4 Other Biotech APIs 56
3.3.2 Biotech API by Customer Base 57
3.3.2.1 Innovative Biologic API 58
3.3.2.2 Generic Biosimilar API 59
3.3.3 Biotech API by Expression Technology 60
3.3.3.1 Mammalian Expression 61
3.3.3.2 Microbial Expression 62
3.3.3.3 Yeast Expression 63
3.3.3.4 Insect Expression 64
3.3.3.5 Other Expression Technologies 65
3.4 HPAPI 66
3.4.1 Branded HPAPI 67
3.4.2 Generic HPAPI 68
4 Segmentation of Global Market by Manufacturing Process 69
4.1 Market Overview by Manufacturing Process 69
4.2 Captive Manufacturing 71
4.2.1 Branded Captive API 72
4.2.2 Generic Captive API 73
4.3 Merchant Manufacturing 74
4.3.1 Merchant Manufacturing by Drug Type 75
4.3.1.1 Branded Merchant API 76
4.3.1.2 Generic Merchant API 77
4.3.2 Merchant Manufacturing by Drug Synthesis 78
4.3.2.1 Merchant Synthetic API 79
4.3.2.2 Merchant Biotech API 80
5 Segmentation of Global Market by Therapeutic Application 81
5.1 Market Overview by Therapeutic Application 81
5.2 Infectious Diseases 83
5.3 Oncology 84
5.4 Ophthalmology 85
5.5 Cardiovascular Disorders 86
5.6 Central Nervous System 87
5.7 Pulmonary Disorders 88
5.8 Orthopedics 89
5.9 Other Applications 90
6 Segmentation of Global Market by Drug Type 91
6.1 Market Overview by Drug Type 91
6.2 Branded Prescription Drugs 93
6.3 Generic Prescription Drugs 94
6.4 OTC Drugs 95
7 Segmentation of Global Market by Region 96
7.1 Geographic Market Overview 2020-2027 96
7.2 North America Market 2020-2027 by Country 102
7.2.1 Overview of North America Market 102
7.2.2 U.S. 105
7.2.3 Canada 109
7.2.4 Mexico 111
7.3 European Market 2020-2027 by Country 113
7.3.1 Overview of European Market 113
7.3.2 UK 116
7.3.3 France 118
7.3.4 Germany 120
7.3.5 Spain 122
7.3.6 Italy 124
7.3.7 Russia 126
7.3.8 Rest of European Market 128
7.4 Asia-Pacific Market 2020-2027 by Country 130
7.4.1 Overview of Asia-Pacific Market 130
7.4.2 China 133
7.4.3 Japan 135
7.4.4 India 138
7.4.5 Australia 140
7.4.6 South Korea 142
7.4.7 Rest of APAC Region 144
7.5 South America Market 2020-2027 by Country 146
7.5.1 Argentina 149
7.5.2 Brazil 151
7.5.3 Chile 153
7.5.4 Rest of South America Market 155
7.6 Rest of World Market 2020-2027 by Country 156
7.6.1 UAE 159
7.6.2 Saudi Arabia 161
7.6.3 South Africa 163
7.6.4 Other National Markets 165
8 Competitive Landscape 166
8.1 Overview of Key Vendors 166
8.2 New Product Launch, Partnership, Investment, and M&A 169
8.3 Company Profiles 170
AbbVie Inc. 170
Astrazeneca 172
Aurobindo Pharma Ltd. 175
BASF 177
Bayer AG 180
Boehringer Ingelheim 182
Dr. Reddy's Laboratories 186
F. Hoffmann-La Roche 188
GlaxoSmithKline plc 190
Lonza Group 194
Lupin Limited 198
Merck & Co., Inc. 200
Mylan NV 202
Novartis International AG 204
Pfizer Inc. 206
Sanofi 210
Sun Pharmaceutical Industries Ltd. 212
Teva Pharmaceutical Industries Ltd. 214
9 Investing in Global Market: Risk Assessment and Management 217
9.1 Risk Evaluation of Global Market 217
9.2 Critical Success Factors (CSFs) 220
Related Reports and Products 223

List of Tables:

Table 1. Snapshot of Global Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2020-2027 23
Table 2. Growth Rate of World Real GDP, 2017-2021 26
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 34
Table 4. Main Product Trends and Market Opportunities in Global Active Pharmaceutical Ingredients (API) Market 38
Table 5. Global Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn 46
Table 6. Global Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2017-2027, $ bn 48
Table 7. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2017-2027, $ bn 52
Table 8. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Customer Base, 2017-2027, $ bn 57
Table 9. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2017-2027, $ bn 60
Table 10. Global Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2017-2027, $ bn 66
Table 11. Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn 69
Table 12. Global Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2017-2027, $ bn 71
Table 13. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2017-2027, $ bn 75
Table 14. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2017-2027, $ bn 78
Table 15. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn 81
Table 16. Global Active Pharmaceutical Ingredients (API) Market by Drug Type, 2017-2027, $ bn 91
Table 17. Global Active Pharmaceutical Ingredients (API) Market by Region, 2017-2027, $ bn 97
Table 18. Total Health Expenditure per capita in PPP International U.S. Dollars by Country 99
Table 19. Leading National Active Pharmaceutical Ingredients (API) Market, 2020 and 2027, $ bn 101
Table 20. North America Active Pharmaceutical Ingredients (API) Market by Country, 2017-2027, $ bn 104
Table 21. U.S. Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn 107
Table 22. U.S. Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn 107
Table 23. U.S. Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn 107
Table 24. Canada Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn 110
Table 25. Canada Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn 110
Table 26. Canada Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn 110
Table 27. Mexico Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn 112
Table 28. Mexico Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn 112
Table 29. Mexico Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn 112
Table 30. Europe Active Pharmaceutical Ingredients (API) Market by Country, 2017-2027, $ bn 115
Table 31. UK Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn 117
Table 32. UK Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn 117
Table 33. UK Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn 117
Table 34. France Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn 119
Table 35. France Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn 119
Table 36. France Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn 119
Table 37. Germany Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn 121
Table 38. Germany Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn 121
Table 39. Germany Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn 121
Table 40. Spain Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn 123
Table 41. Spain Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn 123
Table 42. Spain Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn 123
Table 43. Italy Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn 125
Table 44. Italy Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn 125
Table 45. Italy Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn 125
Table 46. Russia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn 127
Table 47. Russia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn 127
Table 48. Russia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn 127
Table 49. Active Pharmaceutical Ingredients (API) Market in Rest of Europe by Country, 2017-2027, $ bn 129
Table 50. APAC Active Pharmaceutical Ingredients (API) Market by Country, 2017-2027, $ bn 132
Table 51. China Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn 134
Table 52. China Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn 134
Table 53. China Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn 134
Table 54. Japan Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn 137
Table 55. Japan Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn 137
Table 56. Japan Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn 137
Table 57. India Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn 139
Table 58. India Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn 139
Table 59. India Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn 139
Table 60. Australia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn 141
Table 61. Australia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn 141
Table 62. Australia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn 141
Table 63. South Korea Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn 143
Table 64. South Korea Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn 143
Table 65. South Korea Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn 143
Table 66. Active Pharmaceutical Ingredients (API) Market in Rest of APAC by Country, 2017-2027, $ bn 145
Table 67. South America Active Pharmaceutical Ingredients (API) Market by Country, 2017-2027, $ bn 148
Table 68. Argentina Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn 150
Table 69. Argentina Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn 150
Table 70. Argentina Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn 150
Table 71. Brazil Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn 152
Table 72. Brazil Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn 152
Table 73. Brazil Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn 152
Table 74. Chile Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn 154
Table 75. Chile Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn 154
Table 76. Chile Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn 154
Table 77. RoW Active Pharmaceutical Ingredients (API) Market by Country, 2017-2027, $ bn 158
Table 78. UAE Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn 160
Table 79. UAE Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn 160
Table 80. UAE Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn 160
Table 81. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn 162
Table 82. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn 162
Table 83. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn 162
Table 84. South Africa Active Pharmaceutical Ingredients (API) Market by Synthesis, 2017-2027, $ bn 164
Table 85. South Africa Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2017-2027, $ bn 164
Table 86. South Africa Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2017-2027, $ bn 164
Table 87. AbbVie Inc.: Company Snapshot 170
Table 88. AbbVie Inc.: Product Portfolio 170
Table 89. AbbVie Inc.: Revenue, 2017-2019, $ bn 171
Table 90. Astrazeneca: Company Snapshot 172
Table 91. Astrazeneca: Revenue, 2017-2019, $ bn 173
Table 92. Aurobindo Pharma Ltd.: Company Snapshot 175
Table 93. Aurobindo Pharma Ltd.: Product Portfolio 176
Table 94. Aurobindo Pharma Ltd.: Revenue, 2016-2020, $ INR million 176
Table 95. BASF: Company Snapshot 177
Table 96. BASF: Business Segmentation 178
Table 97. BASF: Revenue, 2016-2018, Euro million 178
Table 98. Bayer AG: Company Snapshot 180
Table 99. Bayer AG: Business Segmentation 181
Table 100. Bayer AG: Revenue, 2016-2018, € bn 181
Table 101. Bayer AG: Recent Developments 181
Table 102. Boehringer Ingelheim: Company Snapshot 182
Table 103. Boehringer Ingelheim: Business Segmentation in 2019 183
Table 104. Boehringer Ingelheim: Product Portfolio 183
Table 105. Boehringer Ingelheim: Revenue, 2017-2019, EUR million 184
Table 106. Boehringer Ingelheim: Revenue by Region in 2019 184
Table 107. Boehringer Ingelheim: Recent Developments 184
Table 108. Dr. Reddy's Laboratories: Company Snapshot 186
Table 109. Dr. Reddy's Laboratories: Business Segmentation 186
Table 110. Dr. Reddy's Laboratories: Revenue, 2018-2020, $ bn 187
Table 111. F. Hoffmann-La Roche: Company Snapshot 188
Table 112. AbbVie Inc.: Business Segmentation 188
Table 113. F. Hoffmann-La Roche: Revenue, 2017-2019, $ bn 189
Table 114. GlaxoSmithKline: Company Snapshot 190
Table 115. GlaxoSmithKline: Business Segmentation 191
Table 116. GlaxoSmithKline: Product Portfolio 192
Table 117. GlaxoSmithKline: Revenue, 2016-2018, $ bn 193
Table 118. GlaxoSmithKline: Recent Developments 193
Table 119. Lonza Group: Company Snapshot 194
Table 120. Lonza Group: Business Segmentation in 2018 195
Table 121. Lonza Group: Product Portfolio 195
Table 122. Lonza Group: Revenue, 2017-2019, $ billion 196
Table 123. Lonza Group: Revenue by Region in 2018 196
Table 124. Lonza Group: Recent Developments 197
Table 125. Lupin Limited: Company Snapshot 198
Table 126. Lupin Limited: Business Segmentation 198
Table 127. Lupin Limited: Revenue, 2016-2018, INR billion 199
Table 128. Merck & Co., Inc.: Company Snapshot 200
Table 129. Merck & Co., Inc.: Business Segmentation 200
Table 130. Merck & Co., Inc.: Revenue, 2017-2019, $ bn 201
Table 131. Mylan NV: Company Snapshot 202
Table 132. Mylan NV: Revenue, 2017-2019, $ bn 203
Table 133. Novartis International AG: Company Snapshot 204
Table 134. Novartis International AG: Business Segmentation 204
Table 135. Novartis International AG: Revenue, 2017-2019, $ bn 205
Table 136. Pfizer Inc.: Company Snapshot 206
Table 137. Pfizer Inc.: Business Segmentation 207
Table 138. Pfizer Inc.: Product Portfolio 207
Table 139. Pfizer Inc.: Revenue, 2016-2018, $ bn 208
Table 140. Pfizer Inc.: Recent Developments 208
Table 141. Sanofi: Company Snapshot 210
Table 142. Sanofi: Business Segmentation 210
Table 143. Sanofi: Revenue, 2017-2019, $ bn 211
Table 144. Sun Pharmaceutical Industries Limited: Company Snapshot 212
Table 145. Sun Pharmaceutical Industries Limited: Revenue, 2017-2019, INR bn 213
Table 146. Teva Pharmaceutical Industries Ltd.: Company Snapshot 214
Table 147. Teva Pharmaceutical Industries Ltd.: Business Segmentation 215
Table 148. Teva Pharmaceutical Industries Ltd.: Revenue, 2017-2019, $ bn 215
Table 149. Risk Evaluation for Investing in Global Market, 2020-2027 218
Table 150. Critical Success Factors and Key Takeaways 221

 

 

List of Figures:

Figure 1. Research Method Flow Chart 16
Figure 2. Breakdown of Primary Research 18
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 20
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027 22
Figure 5. Global Active Pharmaceutical Ingredients (API) Market, 2020-2027, $ bn 24
Figure 6. Impact of COVID-19 on Business 28
Figure 7. Primary Drivers and Impact Factors of Global Active Pharmaceutical Ingredients (API) Market 30
Figure 8. GDP per capita in the World, 1960-2018, $ thousand 33
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 33
Figure 10. Primary Restraints and Impact Factors of Global Active Pharmaceutical Ingredients (API) Market 35
Figure 11. Investment Opportunity Analysis 39
Figure 12. Porter’s Fiver Forces Analysis of Global Active Pharmaceutical Ingredients (API) Market 42
Figure 13. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Synthesis, 2020-2027, % of Revenue 46
Figure 14. Contribution to Global 2021-2027 Cumulative Revenue by Synthesis, Value ($ bn) and Share (%) 47
Figure 15. Global Active Pharmaceutical Ingredients (API) Market: Synthetic API, 2017-2027, $ bn 48
Figure 16. Global Active Pharmaceutical Ingredients (API) Market: Branded Synthetic API, 2017-2027, $ bn 49
Figure 17. Global Active Pharmaceutical Ingredients (API) Market: Generic Synthetic API, 2017-2027, $ bn 50
Figure 18. Global Active Pharmaceutical Ingredients (API) Market: Biotech API, 2017-2027, $ bn 51
Figure 19. Global Active Pharmaceutical Ingredients (API) Market: Monoclonal Antibodies, 2017-2027, $ bn 53
Figure 20. Global Active Pharmaceutical Ingredients (API) Market: Recombinant Proteins, 2017-2027, $ bn 54
Figure 21. Global Active Pharmaceutical Ingredients (API) Market: Vaccines, 2017-2027, $ bn 55
Figure 22. Global Active Pharmaceutical Ingredients (API) Market: Other Biotech APIs, 2017-2027, $ bn 56
Figure 23. Global Active Pharmaceutical Ingredients (API) Market: Innovative Biologic API, 2017-2027, $ bn 58
Figure 24. Global Active Pharmaceutical Ingredients (API) Market: Generic Biosimilar API, 2017-2027, $ bn 59
Figure 25. Global Active Pharmaceutical Ingredients (API) Market: Mammalian Expression, 2017-2027, $ bn 61
Figure 26. Global Active Pharmaceutical Ingredients (API) Market: Microbial Expression, 2017-2027, $ bn 62
Figure 27. Global Active Pharmaceutical Ingredients (API) Market: Yeast Expression, 2017-2027, $ bn 63
Figure 28. Global Active Pharmaceutical Ingredients (API) Market: Insect Expression, 2017-2027, $ bn 64
Figure 29. Global Active Pharmaceutical Ingredients (API) Market: Other Expression Technologies, 2017-2027, $ bn 65
Figure 30. Global Active Pharmaceutical Ingredients (API) Market: HPAPI, 2017-2027, $ bn 66
Figure 31. Global Active Pharmaceutical Ingredients (API) Market: Branded HPAPI, 2017-2027, $ bn 67
Figure 32. Global Active Pharmaceutical Ingredients (API) Market: Generic HPAPI, 2017-2027, $ bn 68
Figure 33. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2020-2027, % of Revenue 69
Figure 34. Contribution to Global 2021-2027 Cumulative Revenue by Manufacturing Process, Value ($ bn) and Share (%) 70
Figure 35. Global Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing, 2017-2027, $ bn 71
Figure 36. Global Active Pharmaceutical Ingredients (API) Market: Branded Captive API, 2017-2027, $ bn 72
Figure 37. Global Active Pharmaceutical Ingredients (API) Market: Generic Captive API, 2017-2027, $ bn 73
Figure 38. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing, 2017-2027, $ bn 74
Figure 39. Global Active Pharmaceutical Ingredients (API) Market: Branded Merchant API, 2017-2027, $ bn 76
Figure 40. Global Active Pharmaceutical Ingredients (API) Market: Generic Merchant API, 2017-2027, $ bn 77
Figure 41. Global Active Pharmaceutical Ingredients (API) Market: Merchant Synthetic API, 2017-2027, $ bn 79
Figure 42. Global Active Pharmaceutical Ingredients (API) Market: Merchant Biotech API, 2017-2027, $ bn 80
Figure 43. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2020-2027, % of Revenue 81
Figure 44. Contribution to Global 2021-2027 Cumulative Revenue by Therapeutic Application, Value ($ bn) and Share (%) 82
Figure 45. Global Active Pharmaceutical Ingredients (API) Market: Infectious Diseases, 2017-2027, $ bn 83
Figure 46. Global Active Pharmaceutical Ingredients (API) Market: Oncology, 2017-2027, $ bn 84
Figure 47. Global Active Pharmaceutical Ingredients (API) Market: Ophthalmology , 2017-2027, $ bn 85
Figure 48. Global Active Pharmaceutical Ingredients (API) Market: Cardiovascular Disorders, 2017-2027, $ bn 86
Figure 49. Global Active Pharmaceutical Ingredients (API) Market: Central Nervous System, 2017-2027, $ bn 87
Figure 50. Global Active Pharmaceutical Ingredients (API) Market: Pulmonary Disorders, 2017-2027, $ bn 88
Figure 51. Global Active Pharmaceutical Ingredients (API) Market: Orthopedics, 2017-2027, $ bn 89
Figure 52. Global Active Pharmaceutical Ingredients (API) Market: Other Applications, 2017-2027, $ bn 90
Figure 53. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Drug Type, 2020-2027, % of Revenue 91
Figure 54. Contribution to Global 2021-2027 Cumulative Revenue by Drug Type, Value ($ bn) and Share (%) 92
Figure 55. Global Active Pharmaceutical Ingredients (API) Market: Branded Prescription Drugs, 2017-2027, $ bn 93
Figure 56. Global Active Pharmaceutical Ingredients (API) Market: Generic Prescription Drugs, 2017-2027, $ bn 94
Figure 57. Global Active Pharmaceutical Ingredients (API) Market: OTC Drugs, 2017-2027, $ bn 95
Figure 58. Global Market Snapshot by Region 96
Figure 59. Geographic Spread of Worldwide Active Pharmaceutical Ingredients (API) Market, 2020-2027, % of Revenue 97
Figure 60. Contribution to Global 2021-2027 Cumulative Revenue by Region, Value ($ bn) and Share (%) 98
Figure 61. Health Spending as a Share of GDP by Country, 2017 and 2030 100
Figure 62. North American Active Pharmaceutical Ingredients (API) Market, 2017-2027, $ bn 103
Figure 63. Breakdown of North America Active Pharmaceutical Ingredients (API) Market by Country, 2020 and 2027, % of Revenue 103
Figure 64. Contribution to North America 2021-2027 Cumulative Revenue by Country, Value ($ bn) and Share (%) 104
Figure 65. U.S. Active Pharmaceutical Ingredients (API) Market, 2017-2027, $ bn 106
Figure 66. Canada Active Pharmaceutical Ingredients (API) Market, 2017-2027, $ bn 109
Figure 67. Active Pharmaceutical Ingredients (API) Market in Mexico, 2017-2027, $ bn 111
Figure 68. European Active Pharmaceutical Ingredients (API) Market, 2017-2027, $ bn 114
Figure 69. Breakdown of European Active Pharmaceutical Ingredients (API) Market by Country, 2020 and 2027, % of Revenue 114
Figure 70. Contribution to Europe 2021-2027 Cumulative Revenue by Country, Value ($ bn) and Share (%) 115
Figure 71. Active Pharmaceutical Ingredients (API) Market in UK, 2017-2027, $ bn 116
Figure 72. Active Pharmaceutical Ingredients (API) Market in France, 2017-2027, $ bn 118
Figure 73. Active Pharmaceutical Ingredients (API) Market in Germany, 2017-2027, $ bn 120
Figure 74. Active Pharmaceutical Ingredients (API) Market in Spain, 2017-2027, $ bn 122
Figure 75. Active Pharmaceutical Ingredients (API) Market in Italy, 2017-2027, $ bn 124
Figure 76. Active Pharmaceutical Ingredients (API) Market in Russia, 2017-2027, $ bn 126
Figure 77. Active Pharmaceutical Ingredients (API) Market in Rest of Europe, 2017-2027, $ bn 128
Figure 78. Asia-Pacific Active Pharmaceutical Ingredients (API) Market, 2017-2027, $ bn 131
Figure 79. Breakdown of APAC Active Pharmaceutical Ingredients (API) Market by Country, 2020 and 2027, % of Revenue 131
Figure 80. Contribution to APAC 2021-2027 Cumulative Revenue by Country, Value ($ bn) and Share (%) 132
Figure 81. Active Pharmaceutical Ingredients (API) Market in China, 2017-2027, $ bn 133
Figure 82. Active Pharmaceutical Ingredients (API) Market in Japan, 2017-2027, $ bn 136
Figure 83. Active Pharmaceutical Ingredients (API) Market in India, 2017-2027, $ bn 138
Figure 84. Active Pharmaceutical Ingredients (API) Market in Australia, 2017-2027, $ bn 140
Figure 85. Active Pharmaceutical Ingredients (API) Market in South Korea, 2017-2027, $ bn 142
Figure 86. Active Pharmaceutical Ingredients (API) Market in Rest of APAC, 2017-2027, $ bn 144
Figure 87. South America Active Pharmaceutical Ingredients (API) Market, 2017-2027, $ bn 147
Figure 88. Breakdown of South America Active Pharmaceutical Ingredients (API) Market by Country, 2020 and 2027, % of Revenue 147
Figure 89. Contribution to South America 2021-2027 Cumulative Revenue by Country, Value ($ bn) and Share (%) 148
Figure 90. Active Pharmaceutical Ingredients (API) Market in Argentina, 2017-2027, $ bn 149
Figure 91. Active Pharmaceutical Ingredients (API) Market in Brazil, 2017-2027, $ bn 151
Figure 92. Active Pharmaceutical Ingredients (API) Market in Chile, 2017-2027, $ bn 153
Figure 93. Active Pharmaceutical Ingredients (API) Market in Rest of South America, 2017-2027, $ bn 155
Figure 94. Active Pharmaceutical Ingredients (API) Market in Rest of the World (RoW), 2017-2027, $ bn 157
Figure 95. Breakdown of RoW Active Pharmaceutical Ingredients (API) Market by Country, 2020 and 2027, % of Revenue 157
Figure 96. Contribution to RoW 2021-2027 Cumulative Revenue by Country, Value ($ bn) and Share (%) 158
Figure 97. Active Pharmaceutical Ingredients (API) Market in UAE, 2017-2027, $ bn 159
Figure 98. Active Pharmaceutical Ingredients (API) Market in Saudi Arabia, 2017-2027, $ bn 161
Figure 99. Active Pharmaceutical Ingredients (API) Market in South Africa, 2017-2027, $ bn 163
Figure 100. Growth Stage of Global Active Pharmaceutical Ingredients (API) Industry over the Forecast Period 166
Figure 101. Top products of AstraZeneca based on revenue from 2016 to 2019 (in million U.S. dollars) 173

 

 

 

Reviews

There are yet no reviews for this product.